Skip to Main content Skip to Navigation
Journal articles

Revisiting the molecular interactions between the tumor protein TCTP and the drugs sertraline/thioridazine.

Abstract : TCTP protein is a pharmacological target in cancer and TCTP inhibitors such as sertraline have been evaluated in clinical trials. The direct interaction of TCTP with the drugs sertraline and thioridazine has been reported in vitro by SPR experiments to be in the ~30-50 µM Kd range (Amson et al. Nature Med 2012), supporting a TCTP-dependent mode of action of the drugs on tumor cells. However, the molecular details of the interaction remain elusive although they are crucial to improve the efforts of on-going medicinal chemistry. In addition, TCTP can be phosphorylated by the Plk-1 kinase, which is indicative of poor prognosis in several cancers. The impact of phosphorylation on TCTP structure/dynamics and binding with therapeutical ligands remains unexplored. Here, we combined NMR, TSA, SPR, BLI and ITC techniques to probe the molecular interactions between TCTP with the drugs sertraline and thioridazine. We reveal that drug binding is much weaker than reported with an apparent ~mM Kd and leads to protein destabilization that obscured the analysis of the published SPR data. We further demonstrate by NMR and SAXS that TCTP S46 phosphorylation does not promote tighter interaction between TCTP and sertraline. Accordingly, we question the supported model in which sertraline and thioridazine directly interact with isolated TCTP in tumor cells and discuss alternative modes of action for the drugs in light of current literature.
Complete list of metadata

https://hal.archives-ouvertes.fr/pasteur-03370569
Contributor : Ewen Lescop Connect in order to contact the contributor
Submitted on : Wednesday, September 8, 2021 - 10:18:29 AM
Last modification on : Tuesday, December 7, 2021 - 12:44:01 PM

File

TCTP_sertraline.pdf
Files produced by the author(s)

Identifiers

Citation

Florian Malard, Eric Jacquet, Naima Nhiri, Christina Sizun, Amélie Chabrier, et al.. Revisiting the molecular interactions between the tumor protein TCTP and the drugs sertraline/thioridazine.. ChemMedChem, Wiley-VCH Verlag, In press, ⟨10.1002/cmdc.202100528⟩. ⟨pasteur-03370569v2⟩

Share

Metrics

Record views

184

Files downloads

214